Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
65 Ergebnisse
| JY5S3U | Alnylam Pharmaceuticals Inc./OS/Call [270]/JPMD | - | - | 270,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,923 % | 0,605 | -0,093 | 3,676 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE8QTK | Alnylam Pharmaceuticals Inc./OS/Call [280]/JPMD | - | - | 280,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,914 % | 0,577 | -0,087 | 3,537 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY1431 | Alnylam Pharmaceuticals Inc./OS/Call [280]/JPMD | - | - | 280,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,481 % | 0,567 | -0,094 | 3,838 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY3J4F | Alnylam Pharmaceuticals Inc./OS/Call [280]/JPMD | - | - | 280,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,209 % | 0,596 | -0,074 | 3,127 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE8QTR | Alnylam Pharmaceuticals Inc./OS/Call [290]/JPMD | - | - | 290,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,337 % | 0,540 | -0,086 | 3,693 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9CS0 | Alnylam Pharmaceuticals Inc./OS/Call [290]/JPMD | - | - | 290,000 | call | Alnylam Pharmaceuticals Inc. | - | 58,833 % | 0,574 | -0,074 | 3,205 | 19.03.2027 | 0,100 | JP Morgan | ||
| JY142Y | Alnylam Pharmaceuticals Inc./OS/Call [290]/JPMD | - | - | 290,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,271 % | 0,529 | -0,094 | 3,995 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE6KUS | Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD | - | - | 300,000 | call | Alnylam Pharmaceuticals Inc. | - | 58,586 % | 0,493 | -0,093 | 4,176 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE618K | Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD | - | - | 300,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,061 % | 0,510 | -0,086 | 3,815 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9CS2 | Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD | - | - | 300,000 | call | Alnylam Pharmaceuticals Inc. | - | 58,287 % | 0,538 | -0,074 | 3,341 | 19.03.2027 | 0,100 | JP Morgan | ||
| JY0QBM | Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD | - | - | 300,000 | call | Alnylam Pharmaceuticals Inc. | - | 60,252 % | 0,403 | -0,144 | 6,595 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE69YL | Alnylam Pharmaceuticals Inc./OS/Call [310]/JPMD | - | - | 310,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,727 % | 0,348 | -0,135 | 7,035 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE67DT | Alnylam Pharmaceuticals Inc./OS/Call [310]/JPMD | - | - | 310,000 | call | Alnylam Pharmaceuticals Inc. | - | 58,169 % | 0,457 | -0,091 | 4,348 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE599U | Alnylam Pharmaceuticals Inc./OS/Call [310]/JPMD | - | - | 310,000 | call | Alnylam Pharmaceuticals Inc. | - | 58,513 % | 0,478 | -0,085 | 3,963 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9CS3 | Alnylam Pharmaceuticals Inc./OS/Call [310]/JPMD | - | - | 310,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,895 % | 0,510 | -0,073 | 3,449 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE08JM | Alnylam Pharmaceuticals Inc./OS/Call [320]/JPMD | - | - | 320,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,846 % | 0,296 | -0,125 | 7,420 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE7TCU | Alnylam Pharmaceuticals Inc./OS/Call [320]/JPMD | - | - | 320,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,637 % | 0,421 | -0,088 | 4,533 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE83Q3 | Alnylam Pharmaceuticals Inc./OS/Call [320]/JPMD | - | - | 320,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,654 % | 0,449 | -0,085 | 4,010 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9CS5 | Alnylam Pharmaceuticals Inc./OS/Call [320]/JPMD | - | - | 320,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,489 % | 0,481 | -0,072 | 3,560 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE0XNC | Alnylam Pharmaceuticals Inc./OS/Call [330]/JPMD | - | - | 330,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,047 % | 0,254 | -0,114 | 7,875 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE7TCM | Alnylam Pharmaceuticals Inc./OS/Call [330]/JPMD | - | - | 330,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,521 % | 0,388 | -0,086 | 4,687 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE618G | Alnylam Pharmaceuticals Inc./OS/Call [330]/JPMD | - | - | 330,000 | call | Alnylam Pharmaceuticals Inc. | - | 58,116 % | 0,416 | -0,082 | 4,225 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9CS4 | Alnylam Pharmaceuticals Inc./OS/Call [330]/JPMD | - | - | 330,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,081 % | 0,454 | -0,071 | 3,673 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE12BF | Alnylam Pharmaceuticals Inc./OS/Call [340]/JPMD | - | - | 340,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,490 % | 0,214 | -0,103 | 8,208 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE5016 | Alnylam Pharmaceuticals Inc./OS/Call [340]/JPMD | - | - | 340,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,345 % | 0,356 | -0,083 | 4,852 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE618M | Alnylam Pharmaceuticals Inc./OS/Call [340]/JPMD | - | - | 340,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,637 % | 0,385 | -0,079 | 4,380 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9CS6 | Alnylam Pharmaceuticals Inc./OS/Call [340]/JPMD | - | - | 340,000 | call | Alnylam Pharmaceuticals Inc. | - | 56,816 % | 0,427 | -0,070 | 3,778 | 19.03.2027 | 0,100 | JP Morgan | ||
| JZ6960 | Alnylam Pharmaceuticals Inc./OS/Call [350]/JPMD | - | - | 350,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,573 % | 0,353 | -0,076 | 4,520 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE0028 | Alnylam Pharmaceuticals Inc./OS/Call [350]/JPMD | - | - | 350,000 | call | Alnylam Pharmaceuticals Inc. | - | 62,546 % | 0,198 | -0,103 | 8,007 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE7JLV | Alnylam Pharmaceuticals Inc./OS/Call [350]/JPMD | - | - | 350,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,211 % | 0,326 | -0,080 | 5,010 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE9CS7 | Alnylam Pharmaceuticals Inc./OS/Call [350]/JPMD | - | - | 350,000 | call | Alnylam Pharmaceuticals Inc. | - | 56,593 % | 0,398 | -0,068 | 3,894 | 19.03.2027 | 0,100 | JP Morgan | ||
| JH52VL | Alnylam Pharmaceuticals Inc./OS/Call [360]/JPM | - | - | 360,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,720 % | 0,341 | -0,078 | 4,442 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE5011 | Alnylam Pharmaceuticals Inc./OS/Call [360]/JPMD | - | - | 360,000 | call | Alnylam Pharmaceuticals Inc. | - | 56,570 % | 0,297 | -0,075 | 5,211 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE9CS8 | Alnylam Pharmaceuticals Inc./OS/Call [360]/JPMD | - | - | 360,000 | call | Alnylam Pharmaceuticals Inc. | - | 58,119 % | 0,384 | -0,069 | 3,863 | 19.03.2027 | 0,100 | JP Morgan | ||
| JY0QBN | Alnylam Pharmaceuticals Inc./OS/Call [360]/JPMD | - | - | 360,000 | call | Alnylam Pharmaceuticals Inc. | - | 62,875 % | 0,170 | -0,093 | 8,273 | 18.09.2026 | 0,100 | JP Morgan | ||
| JH7RAB | Alnylam Pharmaceuticals Inc./OS/Call [370]/JPM | - | - | 370,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,120 % | 0,303 | -0,071 | 4,784 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE67DH | Alnylam Pharmaceuticals Inc./OS/Call [370]/JPMD | - | - | 370,000 | call | Alnylam Pharmaceuticals Inc. | - | 59,380 % | 0,285 | -0,077 | 5,067 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE9CS9 | Alnylam Pharmaceuticals Inc./OS/Call [370]/JPMD | - | - | 370,000 | call | Alnylam Pharmaceuticals Inc. | - | 56,182 % | 0,350 | -0,064 | 4,098 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE7JLX | Alnylam Pharmaceuticals Inc./OS/Call [380]/JPMD | - | - | 380,000 | call | Alnylam Pharmaceuticals Inc. | - | 56,579 % | 0,244 | -0,067 | 5,517 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE9CSA | Alnylam Pharmaceuticals Inc./OS/Call [380]/JPMD | - | - | 380,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,674 % | 0,339 | -0,065 | 4,057 | 19.03.2027 | 0,100 | JP Morgan | ||
| JY3VQT | Alnylam Pharmaceuticals Inc./OS/Call [380]/JPMD | - | - | 380,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,222 % | 0,282 | -0,068 | 4,882 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9SME | Alnylam Pharmaceuticals Inc./OS/Call [390]/JPMD | - | - | 390,000 | call | Alnylam Pharmaceuticals Inc. | - | 55,787 % | 0,306 | -0,060 | 4,303 | 19.03.2027 | 0,100 | JP Morgan | ||
| JY2P4J | Alnylam Pharmaceuticals Inc./OS/Call [390]/JPMD | - | - | 390,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,135 % | 0,260 | -0,065 | 5,004 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY2JGF | Alnylam Pharmaceuticals Inc./OS/Call [400]/JPMD | - | - | 400,000 | call | Alnylam Pharmaceuticals Inc. | - | 57,382 % | 0,238 | -0,062 | 5,106 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY3J4G | Alnylam Pharmaceuticals Inc./OS/Put [220]/JPMD | - | - | 220,000 | put | Alnylam Pharmaceuticals Inc. | - | 64,901 % | -0,235 | -0,050 | 2,427 | 19.03.2027 | 0,100 | JP Morgan | ||
| JY5QP2 | Alnylam Pharmaceuticals Inc./OS/Put [220]/JPMD | - | - | 220,000 | put | Alnylam Pharmaceuticals Inc. | - | 63,714 % | -0,221 | -0,062 | 3,440 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE7TCR | Alnylam Pharmaceuticals Inc./OS/Put [240]/JPMD | - | - | 240,000 | put | Alnylam Pharmaceuticals Inc. | - | 62,665 % | -0,286 | -0,069 | 3,181 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE83QE | Alnylam Pharmaceuticals Inc./OS/Put [240]/JPMD | - | - | 240,000 | put | Alnylam Pharmaceuticals Inc. | - | 62,332 % | -0,282 | -0,062 | 2,883 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9CRX | Alnylam Pharmaceuticals Inc./OS/Put [240]/JPMD | - | - | 240,000 | put | Alnylam Pharmaceuticals Inc. | - | 63,756 % | -0,289 | -0,053 | 2,285 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE1087 | Alnylam Pharmaceuticals Inc./OS/Put [260]/JPMD | - | - | 260,000 | put | Alnylam Pharmaceuticals Inc. | - | 63,176 % | -0,373 | -0,130 | 4,902 | 18.09.2026 | 0,100 | JP Morgan |